A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P. Zisimopoulou, P. Evangelakou, J. Tzartos, K. Lazaridis, V. Zouvelou, R. Mantegazza, C. Antozzi, F. Andreetta, A. Evoli, F. Deymeer, G. Saruhan-Direskeneli, H. Durmus, T. Brenner, A. Vaknin, S. Berrih-Aknin, M. Frenkian Cuvelier, T. Stojkovic, M. DeBaets, M. Losen, P. Martinez-MartinezK. A. Kleopa, E. Zamba-Papanicolaou, T. Kyriakides, A. Kostera-Pruszczyk, P. Szczudlik, B. Szyluk, D. Lavrnic, I. Basta, S. Peric, C. Tallaksen, A. Maniaol, S. J. Tzartos*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)139-145
JournalJournal of Autoimmunity
Volume52
DOIs
Publication statusPublished - Aug 2014

Keywords

  • Myasthenia gravis
  • LRP4
  • Autoantibodies Cell based assay
  • Diagnosis
  • Therapy

Cite this